CEA-TRICOM (Therion)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameCEA-TRICOM (Therion)
Drug Alias NamerF-CEA-TRICOM + rV-CEA-TRICOM prime-boost vaccine (Therion)rV-CEA-TRICOM + rF-CEA-TRICOM prime-boost colorectal cancer vaccine (Therion)vaccinia vector-CEA-TRICOM prime + fowl pox vector-CEA-TRICOM boost (Therion)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccineBiologics > Antigen > Tumor antigen +[4] 
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTherion Biologics Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi Pasteur SaTherion Biologics Corp
Active IndicationsN/A
Inactive IndicationsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A